title: Using rodents to model schizophrenia and substance use comorbidity.
abstract: Schizophrenia and substance use disorders (SUD) often occur together, yet it is unclear why this is the case or how best to manage dual diagnosis. Rodent models are well suited to study how genes and environment interact to impact neurodevelopment, brain function and behaviors relevant to dual diagnosis. Indeed a variety of rodent models for schizophrenia display behavioral and physiological features relevant to SUD including: neurodevelopmental models, models of a rare variant (Disc1), to models of common variants (neurexin, dysbindin and neuregulin), and models of various gene-drug interactions. Thus it may be worthwhile to probe models of schizophrenia for insights relevant to SUD and dual diagnosis. However, future studies on dual diagnosis should involve characterization beyond measuring locomotor responses to self-administration tasks, include drug classes other than psychostimulants, and dissect the neuroadaptations that underlie risk for dual diagnosis.
authors.affiliation: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Room 860, Toronto, Ontario M5G 1X5, Canada. enoch.ng@mail.utoronto.ca
authors.forename: Enoch
authors.initials: E
authors.lastname: Ng
authors.forename: Alexander
authors.initials: A
authors.lastname: McGirr
authors.forename: Albert H C
authors.initials: AH
authors.lastname: Wong
authors.forename: John C
authors.initials: JC
authors.lastname: Roder
mesh_terms: D000818:Animals; D015897:Comorbidity; D017831:Diagnosis, Dual (Psychiatry); D004195:Disease Models, Animal; D004777:Environment; D006801:Humans; D012377:Rodentia; D012559:Schizophrenia / Q000453:epidemiology* / Q000235:genetics / Q000473:pathology; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000235:genetics / Q000473:pathology